Abstract
We have routinely used erythropoietin (EPO) by subcutaneous route of administration in all patients entering our chronic peritoneal dialysis (PD) program since its inception in March 1989. The criteria for use of the medication was an anemia with hematocrit (HCT) values less than 30 vol. %. One patient entering the program had been on EPO during the predialysis phase of his illness, while some others had received EPO during prior treatment with hemodialysis (HD). In all cases the route of administration was subcutaneous. This preferential use of subcutaneous EPO was based on our favorable experience with EPO in predialysis patients with severe anemia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Mäher JF, Hirszel P. in: Nolph KD (ed.): üInternational, Eighth Annual CAPD Conference, 1985, pp. 267–296.
Teehan BP, Schleifer CR, Sigler MH, Gilgor GS. Perit Dial Bull 1985; 5: 152–156.
Di Paolo N, Buoncristiani U, Gaggliotti E, Capotondo L, Di Mia M. Peril Dial Bull 1986; 6: 44–45.
Mistry CD, Gokal R, Mallick NP. in: Maher JF, Winchester JF (eds.): Frontiers in Peritoneal Dialysis, New York: Field Rich, 1986, pp. 241–248.
Khanna R, Mactier R, Twardowski ZJ, Nolph KD. Perit Dial Bull 1986; 6: 113–121.
Maiorca R, Cantaluppi A, Cancarini GC, et al. Lancet 1983; 2: 642–644.
Cantaluppi A, Scalamogna A, Castelnovo C, Graziani G. Perit Dial Bull 1986; 6: 58–61.
Junor BJR, Briggs JD, Forwell MA, Dobbie JW, Henderson IA. Perit Dial Bull 1985; 5: 101–104.
Branner FP, Brynger H, Chantler C, et al. Proc Eur Dial Transplant Assoc 1979; 16: 4.
Steinberg SM, Cutler SJ, Novak JW, Nolph KD. The National Institutes of Health CAPD Patient Registry Report, Bethesda, MD: National Institutes of Health, January 1986.
Broyer M, Brunner FP, Brynger H, et al. Proc Eur Dial Transplant Assoc 1983; 20: 3. 17
Drukker, W, History of Hemodialysis, in: Maher JF (ed.): Replacement of Renal Function by Dialysis ( ed. 3 ), The Hague: Martinus Nijhoff, 1989, p. 35.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Publishing Corporation
About this chapter
Cite this chapter
Stern, L., Vernocchi, L., Monstroski, L., Appel, G.B. (1990). Erythropoietin in Continuous Ambulatory Peritoneal Dialysis Patients, 1990 Benefits of the Subcutaneous Route in the First U. S. Experience. In: Avram, M.M., et al. Ambulatory Peritoneal Dialysis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9555-7_2
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9555-7_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9557-1
Online ISBN: 978-1-4615-9555-7
eBook Packages: Springer Book Archive